| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.005 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.45 | 0.007 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.007 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.42 | 0.007 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |